Press Release: Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update
November 27, 2024 01:00 ET
|
Sequana Medical NV
Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update More efficient sodium and fluid removal,...
Press Release: Transparency Notification from Shareholders
November 26, 2024 01:00 ET
|
Sequana Medical NV
Transparency Notification from Shareholders Ghent, Belgium – 26 November 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...
Press Release: Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024
November 20, 2024 01:00 ET
|
Sequana Medical NV
Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024 Ghent, Belgium – 20 November 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or...
Press Release: Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025
November 18, 2024 01:00 ET
|
Sequana Medical NV
Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025 alfapump was very effective in...
Press Release: Sequana Medical Announces New Share Capital Amount and New Number of Shares
November 14, 2024 12:00 ET
|
Sequana Medical NV
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 November 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a...
Press release: SEQUANA MEDICAL ANNOUNCES ADDITIONAL CONVERTIBLE FINANCING OF UP TO EUR 1.0 MILLION FROM EXISTING INVESTORS
October 23, 2024 01:00 ET
|
Sequana Medical NV
SEQUANA MEDICAL ANNOUNCES ADDITIONAL CONVERTIBLE FINANCING OF UP TO EUR 1.0 MILLION FROM EXISTING INVESTORS Ghent, Belgium, 23 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...
Persbericht: SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN
October 21, 2024 12:00 ET
|
Sequana Medical NV
PERSBERICHT GEREGLEMENTEERDE INFORMATIE21 oktober 2024, 06:00 pm CEST SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN Gent, België, 21 oktober 2024 – Sequana...
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
October 21, 2024 12:00 ET
|
Sequana Medical NV
PRESS RELEASEREGULATED INFORMATION21 October 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 21 October 2024 – Sequana Medical NV...
Persbericht: Transparantiekennisgeving van Aandeelhouders
October 10, 2024 11:40 ET
|
Sequana Medical NV
Transparantiekennisgeving van Aandeelhouders Gent, België – 10 oktober 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (de "Vennootschap" of "Sequana Medical"), een pionier in de behandeling van...
Press release: Transparency Notification from Shareholders
October 10, 2024 11:40 ET
|
Sequana Medical NV
Transparency Notification from Shareholders Ghent, Belgium – 10 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...